ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,953Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 807

$596K Total Retail Price of All Prescriptions

Rank: 70 out of 807

390 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 390 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 12,109 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
LEVOTHYROXINE SODIUM 517 484 1 3
OMEPRAZOLE 514 477 2 4
FUROSEMIDE 512 493 3 6
METOPROLOL TARTRATE 413 398 4 8
LISINOPRIL 397 375 5 2
CITALOPRAM HBR 378 375 6 17
SIMVASTATIN 343 325 7 1
POLYETHYLENE GLYCOL 3350 318 318 8 40
WARFARIN SODIUM 290 288 9 10
POTASSIUM CHLORIDE 274 268 10 18
AMLODIPINE BESYLATE 260 260 11 5
ATENOLOL 242 236 12 7
TRAZODONE HCL 219 199 13 25
DONEPEZIL HCL 208 208 14 31
GABAPENTIN 197 190 15 16
QUETIAPINE FUMARATE 187 162 16 66
MIRTAZAPINE 172 154 17 38
LANTUS 151 131 18 45
SERTRALINE HCL 148 119 19 22
IPRATROPIUM-ALBUTEROL 142 142 20 126
RISPERIDONE 127 127 21 85
PREDNISONE 124 98 22 24
LEVETIRACETAM 119 81 23 119
HYDROCHLOROTHIAZIDE 114 114 24 9
TRAMADOL HCL 114 112 24 19
MAPAP 114 114 24 122
NAMENDA 114 114 24 54
NYSTATIN 113 112 28 148
JANTOVEN 106 105 29 37
CYMBALTA 94 90 30 73
OLANZAPINE 90 78 31 119
METOPROLOL SUCCINATE 90 90 31 13
ESCITALOPRAM OXALATE 88 87 33 115
NOVOLOG 87 76 34 84
ALBUTEROL SULFATE 83 63 35 139
LANTUS SOLOSTAR 78 78 36 42
RANITIDINE HCL 77 68 37 34
LIDODERM 76 71 38 96
NYSTOP 76 73 38 125
CARBIDOPA-LEVODOPA 75 73 40 64
SEROQUEL 73 64 41 155
BACLOFEN 69 45 42 123
DIVALPROEX SODIUM 68 56 43 114
ALLOPURINOL 68 67 43 26
ISOSORBIDE MONONITRATE ER 67 67 45 36
KLOR-CON M20 66 65 46 83
ASPIRIN 66 66 46 184
CLOZAPINE 66 56 46 296
ADVAIR DISKUS 62 61 49 33
CLOPIDOGREL 61 56 50 47
LOSARTAN POTASSIUM 60 60 51 14
METFORMIN HCL 60 50 51 12
CEPHALEXIN 57 55 53 135
FAMOTIDINE 57 47 53 90
ALENDRONATE SODIUM 57 57 53 20
TAMSULOSIN HCL 56 55 56 27
DIGOXIN 55 55 57 41
TRIAMCINOLONE ACETONIDE 50 48 58 98
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.